FBXO45 and non-small cell lung carcinoma: Inhibition of Fbxo45 protein stabilized ERK‐specific phosphatase NP‐STEP46 and increased sensitivity to EGFR‐TKI by attenuating the maintenance of pERK activity in NSCLC.